Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
Sarcoidosis associated with neuromyelitis optica.
Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Multiple sclerosis and pregnancy.
Examining the factor structure of the multiple sclerosis impact scale.
Epigenetics and the Modulation of Neuroinflammation.
[Interferons and autoimmune diseases].
Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study.
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosis.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
The frequency of anti-aquaporin-4 Ig g antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in malaysia.
Ecological validity of walking capacity tests in multiple sclerosis.
Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.
B Cells and Autoantibodies in Multiple Sclerosis.
Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration.
Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.
Experience of gratitude, awe and beauty in life among patients with multiple sclerosis and psychiatric disorders.
The use of valproic acid and multiple sclerosis.
Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.
Correction: Intrathecal Infusion of Hydrogen-Rich Normal Saline Attenuates Neuropathic Pain via Inhibition of Activation of Spinal Astrocytes and Microglia in Rats.
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Pages
« first
‹ previous
…
472
473
474
475
476
477
478
479
480
…
next ›
last »